Anti-CD47 gel prevents cancer recurrence after surgery

ZenCapsule Inc. (Los Angeles, Calif.) is developing a localized sprayable gel similar to an anti-CD47 immunotherapeutic gel described in a new paper from University of California Los Angeles researchers that prevented postsurgical cancer recurrence in mice.

Studies have suggested surgery-related inflammation incites growth and spread of dormant cancer cells, and anti-inflammatories or immunotherapies could prevent disease recurrence (see "Anti-inflammatories May Prevent Breast Cancer Recurrence")...